Search research articles
Contact Us
Filters
Showing results (421-430 of 1,709) with videos related to
Page
of 171
Sort By:
Reviews of Infectious Diseases
|
July 1, 1988
Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms
J P Quinn, A E Studemeister, C A DiVincenzo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 11, 2011
(64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen
Senthil R Kumar, Fabio A Gallazzi, Thomas P Quinn, et al.
Neuropeptides
|
June 23, 2009
The human neurokinin B gene, TAC3, and its promoter are regulated by Neuron Restrictive Silencing Factor (NRSF) transcription factor family
S Gillies, K Haddley, S Vasiliou, et al.
Molecular and Cellular Neurosciences
|
November 21, 2000
The human preprotachykinin-A gene promoter has been highly conserved and can drive human-like marker gene expression in the adult mouse CNS
A MacKenzie, C Payne, S Boyle, et al.
Microbial Biotechnology
|
January 26, 2011
The construction of a whole-cell biosensor for phosphonoacetate, based on the LysR-like transcriptional regulator PhnR from Pseudomonas fluorescens 23F
Anna N Kulakova, Leonid A Kulakov, John W McGrath, et al.
Journal of Clinical Microbiology
|
May 9, 1998
Detection of Ureaplasma urealyticum in endotracheal tube aspirates from neonates by PCR
S Nelson, A Matlow, G Johnson, et al.
Neuroscience
|
December 1, 1999
Neuronal-specific and nerve growth factor-inducible expression directed by the preprotachykinin-A promoter delivered by an adeno-associated virus vector
P T Harrison, R G Dalziel, N A Ditchfield, et al.
The Biochemical Journal
|
December 10, 1999
E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer
J M Coulson, C E Fiskerstrand, P J Woll, et al.
Clinical Neuropharmacology
|
December 1, 1992
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease
M J Steiger, F Stocchi, L Bramante, et al.
Biomedical Sciences Instrumentation
|
May 12, 2004
Constitutive models for a poly(e-caprolactone) scaffold
T P Quinn, T L Oreskovic, C N McCowan, et al.
Page
of 171
Search research articles
Search
Showing results (421-430 of 1,709) with videos related to
Sort By:
Page
of 171
Reviews of Infectious Diseases
|
July 1, 1988
Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms
J P Quinn, A E Studemeister, C A DiVincenzo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 11, 2011
(64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen
Senthil R Kumar, Fabio A Gallazzi, Thomas P Quinn, et al.
Neuropeptides
|
June 23, 2009
The human neurokinin B gene, TAC3, and its promoter are regulated by Neuron Restrictive Silencing Factor (NRSF) transcription factor family
S Gillies, K Haddley, S Vasiliou, et al.
Molecular and Cellular Neurosciences
|
November 21, 2000
The human preprotachykinin-A gene promoter has been highly conserved and can drive human-like marker gene expression in the adult mouse CNS
A MacKenzie, C Payne, S Boyle, et al.
Microbial Biotechnology
|
January 26, 2011
The construction of a whole-cell biosensor for phosphonoacetate, based on the LysR-like transcriptional regulator PhnR from Pseudomonas fluorescens 23F
Anna N Kulakova, Leonid A Kulakov, John W McGrath, et al.
Journal of Clinical Microbiology
|
May 9, 1998
Detection of Ureaplasma urealyticum in endotracheal tube aspirates from neonates by PCR
S Nelson, A Matlow, G Johnson, et al.
Neuroscience
|
December 1, 1999
Neuronal-specific and nerve growth factor-inducible expression directed by the preprotachykinin-A promoter delivered by an adeno-associated virus vector
P T Harrison, R G Dalziel, N A Ditchfield, et al.
The Biochemical Journal
|
December 10, 1999
E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer
J M Coulson, C E Fiskerstrand, P J Woll, et al.
Clinical Neuropharmacology
|
December 1, 1992
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease
M J Steiger, F Stocchi, L Bramante, et al.
Biomedical Sciences Instrumentation
|
May 12, 2004
Constitutive models for a poly(e-caprolactone) scaffold
T P Quinn, T L Oreskovic, C N McCowan, et al.
Page
of 171